Compare Krispy Kreme Inc (DNUT) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Krispy Kreme Inc vs Zoetis Inc — how do they compare? Krispy Kreme Inc trades at $2.95 (market cap $521.37M), while Zoetis Inc trades at $74.42 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 57.9× Krispy Kreme Inc's market cap, and Krispy Kreme Inc pays the higher dividend (3.47%). Which is the better fit depends on your goals — on Pluang, investors hold Krispy Kreme Inc for 45 Days and Zoetis Inc for 70 Days on average.
| DNUT | ZTS | |
|---|---|---|
Market Cap | $521.37M | $30.20B |
Volume | 2,293,015 | 6,175,327 |
Sector | Consumer Staples | Health |
52-Week High | $4.70 | $147.53 |
52-Week Low | $2.87 | $69.09 |
Typical Hold Time | 45 Days | 70 Days |
Enterprise Value | $1.76B | $37.76B |
Dividend Yield | 3.47% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Krispy Kreme (DNUT) trades at $2.945, up 0.86% with a bullish technical signal despite mixed earnings. The company shows strong gross margins (75.19%) but negative net income (-$515.77M for 2025) and declining revenue trends. Analyst sentiment is positive with 50% buy ratings, though recent news highlights ongoing legal investigations into fiduciary duties.
Investment outlook remains cautious due to profitability challenges and legal overhangs, offset by low valuation multiples (P/S 0.35) and product innovation. Key risks include sustained losses, debt burden, and litigation outcomes. Upside depends on margin improvement and successful new launches.
Zoetis (ZTS) trades at $74.38, up 3.96% in the last session, with a bullish technical signal and strong profitability metrics including a 71.67% gross margin and 27.69% net income margin. Recent earnings show mixed results, with a beat in Q2 2026 but a miss in Q1 2026, while Q3 2026 results are pending. The company maintains robust cash flow from operations of $2.90B in 2025 and a solid balance sheet with $1.99B in cash. Analyst consensus is a Buy with a $87.33 price target, though sentiment is tempered by near-term competitive pressures.
The outlook for ZTS is cautiously optimistic, supported by industry-leading margins and a diversified product portfolio, but faces headwinds from U.S. companion animal market weakness and increased competition. Investment opportunity lies in its undervalued P/E of 11.92 relative to growth potential, while risks include pricing erosion and volume declines. The stock's current level near resistance at $74 suggests potential for consolidation before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Krispy Kreme Inc
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
